Question

Amy Dyken, controller at Metlock Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Metlock's financial statements. Below is selected financial information for the fiscal year ended June 30, 2017 METLOCK PHARMACEUTICAL INDUSTRIES SELECTED BALANCE SHEET INFORMATION JUNE 30, 2017 Long-term debt Notes payable, 10% 8% convertible bonds payable 10% bonds payable $1,020,000 5,080,000 6,110,000 $12,210,000 Total long-term debt Shareholders' equity Preferred stock, 6% cumulative, $50 par value, 98,000 shares authorized, 24,500 shares issued and outstanding $1,225,000 Common stock, $1 par, 10,200,000 shares authorized, 1,020,000 shares issued and outstanding 1,020,000 Additional paid-in capital 3,990,000 Retained earnings 5,900,000 Total shareholders' equity $12,135,000 The following transactions have also occurred at Metlock. 1. Options were granted on July 1, 2016, to purchase 200,000 shares at $15 per share. Although no options were exercised during fiscal year 2017, the average price per common share during fiscal year 2017 was $20 per share. 2. Each bond was issued at face value. The 8% convertible bonds will convert into common stock at 50 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2016. 3. The preferred stock was issued in 2016. 4. There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2017, 5. The 1,020,000 shares of common stock were outstanding for the entire 2017 fiscal year. . Net income for fiscal year 2017 was $1,530,000, and the average income tax rate is 40% For the fiscal year ended June 30, 2017, calculate the following for Metlock Pharmaceutical Industries. (Round answers to 2 decimal places, e.g. $2.45.) (a) Basic earnings per share. Basic earnings per share (b) Diluted earnings per share. Diluted eamings per shares

Answer 1

PART A

Basic earnings per share = (Net income - Preferred dividend ) / Weighted avg. no. of shares of common stock outstanding

***preference dividend = 6% x 50 x 24500 = $ 73,500

= ($1,530,000 - $ 73,500) / 1,020,000 = $ 1456500 / 1020000

= $1.42 (rounded off)

PART B

Average market price ($20) > option price ($15), so the stock options are dilutive

Incremental Shares = Market Price - Option Price / Market Price* Number of options or warrants

Incremental Shares = $20 - $15 / $20*200,000 = 50,000 shares

*Incremental Shares = 50,000

**Interest on convertible bonds (net of tax) = 5080000*8%*(1-0.40) = $ 243,840

*** Converted common shares = 5080000/1000*50 = 254,000

Diluted earnings per share = Net Income - Preferred Dividends + Interest (net of tax) / Average Common Shares + Potentially Dilutive Common Shares

($1,530,000 - $ 73,500 + $ 243,840) / 1020000 + 50000 + 254000 = $ 1700340 / 1324000 = $ 1.28

Hope this helps, if not please let know in comments. We expert here put lots of effort to give correct and quality answer to students. Please mark the answer as helpful for the efforts put, it will mean alot. Thanks